None listed
Conditions
Brief summary
This pilot study is aiming to evaluate the effect of Reiki on pain, anxiety and patient experience in people living with cancer Who is it for? You may be eligible to join this study if you are aged 18 years or above, have been diagnosed with cancer (stage I – III) and experiencing cancer-related pain and/or anxiety. You also need to be English-speaking, sufficient to complete the survey, able to provide informed consent and be clinically stable at the time of participation. Study details All participants will receive a once-off free 30 min Reiki therapy session with a professional Reiki practitioner in the practitioner’s private practice. Participants will complete surveys at before and after the session to determine changes in anxiety, pain, wellbeing and experiences with Reiki therapy. This study will provide preliminary evidence to inform future research on Reiki as a supportive therapy for improving wellbeing among people living with cancer.
Interventions
Reiki is sometimes described as a “biofield therapy.” This means it focuses on the idea of energy in and around the body. Reiki aims to support the natural flow of this energy to help the body feel more balanced and calm. During a Reiki session, the practitioner aims to support this energy flow, while the person receiving Reiki simply relaxes. The Reiki practitioner places their hands lightly on or just above a person’s body. The goal is to support the body’s natural ability to heal itself. Performed by Suzanne King, who has been a professional Reiki practitioner since 2019 and a Master / Teacher since 28 Oct 2024. Suzanne is a Member of the International Association of Reiki Professionals (IARP) and a Member of the International Institute for Complementary Therapists (IICT). Reiki is delivered face to face to individuals The Reiki therapy session will be 30 minutes duration, one-off The Reiki therapy will be delivered in a private clinic The participants will be provided with an appointment reminder prior to attending
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria: • People aged 18 years and above • People diagnosed with all types of cancer (stage I – III). • English-speaking, sufficient to complete the survey • Able to provide informed consent • Clinically stable at the time of participation • Self reports experiencing pain and/or anxiety related to cancer or its treatment
Exclusion criteria
Exclusion criteria: • Paediatric patients • People diagnosed with stage IV cancer • Acute medical or psychiatric instability that would preclude safe participation. • Cognitive impairment (including from use of analgesia or other treatments) limiting capacity for informed consent or study participation